Table 1: Clinical data on 31 consecutive patients given chemotherapy through a permanent intraperitoneal port placed prior to the closure of the abdomen.

Gender
 Male16
 Female15
Age
 Median49
 Range32–74
Diagnosis
 Peritoneal mesothelioma19
 Appendiceal adenocarcinoma5
 Papillary serous cancer3
 Pancreas cancer3
 Rectal cancer1
Cytoreduction
 Complete or near complete (CC-0/CC-1)23
 Incomplete cytoreduction8
% of patients completing 5 or more cycles of with adverse events requiring removal of intraperitoneal port
 Complete or near complete cytoreduction9% (2/23)
 Incomplete cytoreduction75% (6/8)